Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,223 | -8,800 | -20,925 | -12,880 | -10,219 |
| Depreciation Amortization | 77 | 87 | 99 | 147 | 163 |
| Accounts payable and accrued liabilities | 878 | 122 | -253 | 29 | -337 |
| Other Working Capital | 1,066 | -881 | 286 | 525 | 317 |
| Other Operating Activity | 885 | 1,714 | 14,482 | 7,117 | 87 |
| Operating Cash Flow | $-7,317 | $-7,758 | $-6,311 | $-5,062 | $-9,989 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,500 | 3,000 | -3,000 | N/A | N/A |
| PPE Investments | -57 | -83 | -78 | 18 | -59 |
| Other Investing Activity | 0 | 0 | -15 | -2 | -53 |
| Investing Cash Flow | $-5,557 | $2,917 | $-3,093 | $16 | $-112 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 500 | 500 |
| Debt Repayment | N/A | N/A | -5 | -29 | -117 |
| Common Stock Issued | 9,495 | 1,947 | 15,684 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -12 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 9,199 | 3,330 |
| Financing Cash Flow | $9,495 | $1,947 | $15,667 | $9,670 | $3,713 |
| Beginning Cash Position | 8,496 | 11,390 | 5,127 | 503 | 6,891 |
| End Cash Position | 5,117 | 8,496 | 11,390 | 5,127 | 503 |
| Net Cash Flow | $-3,379 | $-2,894 | $6,263 | $4,624 | $-6,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,317 | -7,758 | -6,311 | -5,062 | -9,989 |
| Capital Expenditure | -57 | -95 | -78 | -15 | -59 |
| Free Cash Flow | -7,374 | -7,853 | -6,389 | -5,077 | -10,048 |